Navigation Links
Innovative BioDefense Introduces Zylast Antiseptic Lotion

LAKE FOREST, Calif., July 30, 2013 /PRNewswire/ -- Innovative BioDefense Inc., the developer of a full product line of Zylast™ antiseptic products for use in healthcare, nursing, food preparation, schools, cruise ships, and homes, introduces Zylast Lotion, available in 2 & 8 oz bottles, or in ADA-approved, wall-mounted dispensers.  Zylast Lotion is protected by patents and other intellectual property and can be viewed at

In clinical and laboratory studies, Zylast Lotion has been demonstrated to kill very rapidly a wide spectrum of germs, including E. Coli (99.9999%), S. Aureus (99.9997%), K. Pneumoniae (99.9999%), and S. Pyogenes (99.9999%), while being persistent for six hours after application.  The active ingredient is benzethonium chloride (BZT, 0.2%), together with a proprietary blend of adjuvants that enhance the persistence and rapid kill.  Innovative BioDefense has posted Time-Kill and Persistence papers on its website at with information on the study results.

Clinical studies have shown that use of Zylast Lotion reduces illness absenteeism in schools by 41.6% among students and 24.7% among teachers and staff.  The Lotion is all-natural, water-based, and Triclosan-free.

"First, the Zylast products are persistent for six hours, so children are protected beyond the 15-second lifespan of an alcohol sanitizer.  Second, the Zylast Lotion is effective against pathogens like the Norovirus, rotavirus, and the common cold – some of the most prevalent diseases among children, and germs against which alcohol sanitizers are relatively ineffective.  Finally, the product is water-based and moisturizes the hands, so children and staff actually like using it, which greatly improves compliance." – Dr. Beth McNichol

Zylast Lotion should be used by healthcare and dental workers, teachers and school personnel, food preparers and servers, parents and in long-term care facilities in order to help assure that harmful bacteria and viruses are killed and the likelihood of contagion reduced.

The retail cost of Zylast Lotion is $71.52 for a case (24 bottles) of 2 ounce bottles or $2.98 a bottle; $106.56 for a case (12) of 8 ounce bottles or $8.88 a bottle; or 178.26 for a case (six) of 1,000 ml (33.8 ounce) cartridges for wall mounting or $29.71 a cartridge. Automatic and manual dispensers are also available.

The product is available for immediate delivery and can be ordered by visiting

About Zylast
Zylast™ is a developer, manufacturer and marketer of a full line of antiseptic products for use by healthcare professionals, businesses and consumers.  Zylast products, based on proprietary and patented combinations of pharmaceutical ingredients, are owned by Innovative BioDefense Inc., a privately held company headquartered in Lake Forest, CA. 

For more information, visit

SOURCE Innovative BioDefense Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Innovative Cancer Treatment Supported by NICE
2. Innovative Krebsbehandlung wird von NICE unterstützt
3. UBM Canon and MD+DI Proudly Announce 27 Innovative Products as Winners of the 2013 Medical Design Excellence Awards
4. Andrews Institute offers innovative technology for spine surgery
5. Sirtex To Distribute Surefire Medicals Innovative Infusion System in Australia and Asia Pacific Markets
6. Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies
7. Romanoff Joins Innovative Statewide Program to Combat Abuse of Prescription Pain Medications
8. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
9. BlueBin Inc. Launches to Deliver Innovative Overhaul for Ailing Healthcare Supply Chain
10. VUCA Health Announces Rapid Adoption of its MedsOnCue Digital Patient Engagement Solution Supporting Health Literacy by Innovative Pharmacies across 19 States
11. TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map
Post Your Comments:
(Date:11/26/2015)... 26 november 2015 AAIPharma Services ... geplande investering aan van ten minste $15,8 ... en het mondiale hoofdkantoor in ... resulteren in extra kantoorruimte en extra capaciteit ... groeiende behoeften van de farmaceutische en biotechnologische ...
(Date:11/26/2015)... November 26, 2015 ... nieuwe aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie ... ) --> ... (Photo: ) ... Medisch Centrum (LUMC) blijkt ...
(Date:11/26/2015)... Research and Markets ( ) has announced the addition ... 2019 - Rise in Cardiac Disorders and Growing Awareness among ... offering. Boston scientific and ... and others. --> The market is dominated ... scientific and others. Asia ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, "Voices in ... that delves into an array of issues that are presently affecting Americans. Dedicated to ... dialogue, this show is changing the subjects consumers focus on, one episode at a ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... ... California Medical Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine at ... They observed that both STEMI and Sepsis conditions present in similar ways and require ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... real-time eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean ... Nuclear Medicine tests directly from their electronic medical record (EMR) without the need ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... process, participated in the 61st annual Employee Benefits Conference. The Employee Benefits Conference ... Sunday, November 8th through Wednesday, November 11th, 2015. The conference was held at ...
(Date:11/25/2015)... Indianapolis, IN (PRWEB) , ... November 25, 2015 ... ... clean water accessible for all, Water For Empowerment ™ attracts volunteers together ... on clean water by empowering women as key stakeholders in the process. The ...
Breaking Medicine News(10 mins):